Cargando…
Hippocampus-dependent cognitive enhancement induced by systemic gintonin administration
BACKGROUND: A number of neurological and neurodegenerative diseases share impaired cognition as a common symptom. Therefore, the development of clinically applicable therapies to enhance cognition has yielded significant interest. Previously, we have shown that activation of lysophosphatidic acid re...
Autores principales: | Kim, Sungmin, Kim, Min-Soo, Park, Kwanghoon, Kim, Hyeon-Joong, Jung, Seok-Won, Nah, Seung-Yeol, Han, Jung-Soo, Chung, ChiHye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703807/ https://www.ncbi.nlm.nih.gov/pubmed/26843822 http://dx.doi.org/10.1016/j.jgr.2015.05.001 |
Ejemplares similares
-
Oral Administration of Gintonin Attenuates Cholinergic Impairments by Scopolamine, Amyloid-β Protein, and Mouse Model of Alzheimer’s Disease
por: Kim, Hyeon-Joong, et al.
Publicado: (2015) -
Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions
por: Choi, Sun-Hye, et al.
Publicado: (2015) -
Bioactive lipids in gintonin-enriched fraction from ginseng
por: Cho, Hee-Jung, et al.
Publicado: (2019) -
A brief method for preparation of gintonin-enriched fraction from ginseng
por: Choi, Sun-Hye, et al.
Publicado: (2015) -
Gintonin absorption in intestinal model systems
por: Lee, Byung-Hwan, et al.
Publicado: (2018)